Patents by Inventor Heui II Kang

Heui II Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8188114
    Abstract: The present invention provides novel pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: May 29, 2012
    Assignee: Yuhan Corporation
    Inventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Chan-Sun Park, Seok-Hee Han, Myung-Hun Cha, Heui II Kang, Sun-Young Jang
  • Publication number: 20100069430
    Abstract: The present invention provides novel pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.
    Type: Application
    Filed: November 6, 2009
    Publication date: March 18, 2010
    Applicant: Yuhan Corporation
    Inventors: Jae-Gyu KIM, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Chan-Sun Park, Seok-Hee Han, Myung-Hun Cha, Heui-II Kang, Sun-Young Jang
  • Patent number: 7196177
    Abstract: An antibody variable region of a monoclonal antibody specifically binding to human tumor necrosis factor-? contains at least one of a heavy chain variable region and a light chain variable region having specific complementarity determining regions therein. A nucleic acid molecule encoding the same, a recombinant vector containing the nucleic acid molecule, and a cell transformed with the recombinant vector are also provided.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: March 27, 2007
    Assignee: Yuhan Corporation
    Inventors: Heui II Kang, In Young Ko, Moo Young Song, Chang Seok Kim, Sang Koo Park, Jae Sun Lee, Tae Hyoung Yoo, Kang In Na